Robert Gardner Harrison net worth and biography

Robert Harrison Biography and Net Worth

Information Advisor of Sera Prognostics

Rob Harrison serves as an Information Technology Advisor to Sera Prognostics. During his tenure with the Company, including service as Chief Information Officer, he helped guide Sera’s technology strategy, infrastructure development, and information management initiatives. With more than 30 years of executive technology leadership experience, Rob previously served as Chief Information Officer at Myriad Genetics, where he played a key role in building the technology infrastructure that supported the company’s growth into a global precision medicine leader. He remains active in the technology community through organizations including the Utah Technology Council and AIM Utah CIO Council.

What is Robert Gardner Harrison's net worth?: The estimated net worth of Robert Gardner Harrison is at least $158.79 thousand as of March 11th, 2026. Mr. Harrison owns 76,712 shares of Sera Prognostics stock worth more than $158,794 as of September 18th. This net worth estimate does not reflect any other assets that Mr. Harrison may own. Learn More about Robert Gardner Harrison's net worth.
How do I contact Robert Gardner Harrison?: The corporate mailing address for Mr. Harrison and other Sera Prognostics executives is 2749 E. Parleys Way, Suite 200, Salt Lake City, UT, 84109. Sera Prognostics can also be reached via phone at 801-990-0520 and via email at [email protected]. Learn More on Robert Gardner Harrison's contact information.
Has Robert Gardner Harrison been buying or selling shares of Sera Prognostics?: Robert Gardner Harrison has not been actively trading shares of Sera Prognostics within the last three months. Most recently, Robert Gardner Harrison sold 716 shares of the business's stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $2.04, for a transaction totalling $1,460.64. Following the completion of the sale, the insider now directly owns 76,712 shares of the company's stock, valued at $156,492.48. Learn More on Robert Gardner Harrison's trading history.
Who are Sera Prognostics' active insiders?: Sera Prognostics' insider roster includes Austin Aerts (Strategic Advisor), John Boniface (Chief Scientific Officer), Robert Harrison (Information Advisor), Benjamin Jackson (General Counsel), Paul Kearney (Data Science Advisor), Sandra Lawrence (Director), Mansoor Mirza (Director), and Joshua Phillips (Director). Learn More on Sera Prognostics' active insiders.
Are insiders buying or selling shares of Sera Prognostics?: In the last twelve months, insiders at the sold shares 39 times. They sold a total of 167,112 shares worth more than $394,436.33. The most recent insider tranaction occured on September, 10th when insider Dyaarl Lee Jr. Anderson sold 1,800 shares worth more than $3,600.00. Insiders at Sera Prognostics own 11.3% of the company. Learn More about insider trades at Sera Prognostics.
Information on this page was last updated on 9/10/2026.

Robert Gardner Harrison Insider Trading History at Sera Prognostics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/11/2026	Sell	716	$2.04	$1,460.64	76,712
3/9/2026	Sell	3,360	$1.96	$6,585.60	77,428
2/24/2026	Sell	2,000	$2.34	$4,680.00	80,788
1/27/2026	Sell	2,000	$2.97	$5,940.00	82,788
12/30/2025	Sell	2,000	$3.00	$6,000.00	84,788
12/10/2025	Sell	616	$3.31	$2,038.96	86,788
11/4/2025	Sell	2,000	$3.07	$6,140.00	95,932
10/7/2025	Sell	2,000	$3.18	$6,360.00	97,932
9/11/2025	Sell	645	$3.13	$2,018.85	99,932
9/9/2025	Sell	2,000	$3.05	$6,100.00	100,577
8/20/2025	Sell	6,000	$2.22	$13,320.00	102,577
6/10/2025	Sell	667	$1.48	$987.16	114,539
2/11/2025	Sell	554	$3.97	$2,199.38	114,019
1/13/2025	Sell	2,264	$6.47	$14,648.08	114,573
1/10/2025	Sell	14,209	$7.39	$105,004.51	116,837
6/5/2023	Sell	5,000	$3.23	$16,150.00	28,500

Robert Gardner Harrison Buying and Selling Activity at Sera Prognostics

Sera Prognostics Company Overview

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Today's Range

Now: $2.08

$2.04

$2.08

50 Day Range

MA: $2.05

$1.92

$2.27

2 Week Range

Now: $2.08

$1.56

$3.95

Volume

7,205 shs

Average Volume

23,442 shs

Market Capitalization

$81.86 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.98